Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4284-4292
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4284
Figure 2
Figure 2 Cumulative survival rates in the non-hepatitis B virus infection group, HBsAg-positive group and HBsAg-negative/HBcAb positive group after allogeneic hematopoietic stem cell transplantation. HBcAb: Hepatitis B core antibody; HBsAg: Hepatitis B surface antigen.